MEWA 健康经济与成果研究 (HEOR) 服务市场基于(关键地区、市场参与者、规模和份额)- 到 2030 年的预测

  • Report Code : TIPRE00030076
  • Category : Healthcare IT
  • Status : Published
  • No. of Pages : 88
Buy Now

[研究报告]MEWA健康经济学与成果研究(HEOR)市场规模预计将从2022年的3447万美元增至2030年的5790万美元。预计2022年至2030年市场复合年增长率为6.7% .
市场洞察和分析师观点:
健康经济学侧重于衡量和评估健康干预措施的结果。结果研究涵盖一系列科学学科,有助于评估健康干预措施对患者的影响。因此,健康经济学和结果研究(HEOR)结合了两个领域,为医疗保健决策者提供有意义的数据和见解。随着政府和其他付款人努力解决如何以可承受的成本实现最佳健康结果,人们对 HEOR 的兴趣呈指数级增长。 HEOR 可以帮助医疗保健决策者(包括医生、政府、付款人、卫生部、患者等)适当地比较和选择可用的选项。不断增长的生物技术和制药公司以及药物开发和不断增加的医疗保健支出正在推动 MEWA HEOR 市场。然而,对获取真实世界数据 (RWD) 的限制阻碍了市场增长。
增长动力和挑战:
MEWA 不断开展药物开发活动,以提供优质药物并改善生活,因为慢性病增加和人口老龄化。为了推动业务发展,需要了解卫生经济学及其结果。因此,市场参与者很难在整个开发过程中设计产品及其生命周期。许多公司外包健康经济学和结果研究 (HEOR) 服务,以了解法规、医疗保健覆盖范围和准入决策,并确定有利于特定患者群体的干预措施。因此,多家知名公司将HEOR服务外包以节省生产成本。 HEOR 服务提供商帮助制药和生物技术公司向各自的利益相关者(如医生、付款人和患者)解释其创新的价值。鉴于经济增长和改善健康状况的潜力,中东的生物技术行业正在吸引越来越多的关注和投资。这种合作伙伴关系预计将促进中东地区的 HEOR 服务。受世界上增长最快、发展程度最高的大陆未满足的健康需求的吸引,中国制药公司也通过在当地药品生产设施上投资数十亿美元进入非洲。该地区制药公司的投资正在推动市场增长。
中东的医疗保健支出迅速增加,导致对新型创新医疗保健解决方案的需求不断增长。据迪拜商会报告显示,沙特阿拉伯和阿联酋在中东生物技术市场中占有最大的市场份额,预计到2028年将达到260万美元。在2023年联邦预算中,阿联酋拨款1000万美元13亿用于社区医疗保健和保障。此外,不同的人口特征和健康结果等也是西非的特点。包括西非在内的撒哈拉以南非洲地区的卫生系统长期以来承受着传染病和非传染性疾病的双重负担。各国政府支持卫生部门的技术发展,以提高西非的生活水平。因此,我们实施了政策,通过投资先进技术(如精密设备、诊断项目和高质量治疗药物)来提供优质医疗保健。鼓励对卫生部门的投资,因为它们可以促进人力资本发展和人民福祉,进而促进该地区的经济增长。因此,MEWA 不断增长的医疗保健支出对 HEOR 服务市场的增长产生了积极影响。
HEOR 服务主要基于分析 RWD,并得出现实世界证据 (RWE)。在医疗保健行业,正在进行无数的研究和开发,因此在临床研究期间和之后产生了巨大的数据库。公司无法存储和管理数据;因此,他们将数据维护外包。由于安全和个人原因,HEOR 服务提供商很难从第三方公司收集数据并生成 RWE。此外,RWD 的访问受到严格监管。所有者不允许访问他们的数据,因此为任何新产品发布和开发生成证据都变得具有挑战性。与付款人共享数据也受到限制,这进一步限制了 HEOR 服务提供商收集有关医疗保健行业发展领域的重要信息。因此,对 RWD 的访问限制限制了 MEWA HEOR 服务市场的增长。
战略见解
报告细分和范围:
“中东和西非健康经济与结果研究 (HEOR) 服务市场”被细分基于服务、服务提供商、最终用户和地区。
细分分析:
基于服务,MEWA 健康经济学和结果研究 (HEOR) 服务市场细分为临床结果、经济建模/评估、市场访问解决方案和报销,以及现实世界的数据分析和信息系统。临床结果细分市场在 2022 年占据最大的市场份额。预计现实世界数据分析和信息系统细分市场在 2022 年至 2030 年期间复合年增长率最高,为 7.5%。临床结果研究对于了解治疗对患者的影响非常重要。它还研究特定候选药物的死亡率和发病率、治疗效果和功能。临床结果评估提供定量评级以表明患者健康状况的某些方面。此外,结果评估用于全面概述临床研究。 2020 年 7 月,Certara 在全球范围内推出了 COVID-19 临床结果数据库,以提供有关 COVID-19 研究的实时信息。此外,该数据库还将帮助根据全球 500 多项注册研究确定潜在的病毒感染疫苗和疗法的可行性。此外,现实世界的数据分析被广泛用于快速跟踪罕见疾病的药物开发。此外,现实世界数据分析的好处吸引制药公司在临床研究中实施这些方法。 2023年5月,Komodo Health宣布其真实世界证据(RWE)技术平台用于帮助17项新的健康经济学和结果研究(HEOR)研究,这些研究在国际药物经济学和结果研究学会2023年全球会议上进行了展示(ISPOR)。对信息系统和现实世界数据分析的认识不断提高,产生了巨大的市场潜力。此外,这些公司正在实施各种战略,以证明自己在全球市场的存在。
MEWA 健康经济学和结果研究 (HEOR) 服务市场按服务提供商划分,分为合同研究组织和咨询机构。合同研究组织细分市场在 2022 年占据更大的市场份额,预计 2022 年至 2030 年期间复合年增长率将更高。
合同研究组织为生物制药、医疗器械、制药和生物技术公司提供以下方面的研究服务支持:合同基础。 2022 年 11 月,IQVIA 和 Clalit Health Services 合作在以色列推出第一个 Prime Site,以推进研究。此次合作结合了 IQVIA 和 Clalit 的临床试验交付、数据、基因组学和现实世界研究能力。据估计,成本和时间优化以及较低投资等优势将对合同研究组织细分市场的增长产生积极影响。
MEWA 健康经济学和结果研究 (HEOR) 服务市场按最终用户划分为生物技术/制药公司、医疗保健付款人、政府组织和医疗保健提供者。生物技术/制药公司细分市场在 2022 年占据最大市场份额,预计 2022-2030 年复合年增长率最高。生物技术和制药公司广泛采用 HEOR 服务来改善产品开发、市场准入和经济效益。此外,公司对产品和市场优化的投资不断增加可能会推动细分市场的增长。
区域分析:
根据国家/地区,健康经济学和结果研究 (HEOR) 服务市场分为沙特阿拉伯、阿联酋、卡塔尔、科威特以及 MEWA 的其他地区。沙特阿拉伯占据最大的市场份额,其次是阿联酋。市场增长归因于药品支出的增长,这是由于人们对国家医疗保健干预措施的经济评估的兴趣日益浓厚。国家卫生预算的大幅增加预计也将增加对制药行业的需求。 2019年,沙特卫生预算较上年增长8%,达460亿美元。沙特阿拉伯也有大量临床试验正在进行中。候选药物成功通过临床试验并实现批量生产可能会产生对连续制造等高效制造程序的需求。例如,根据 ClinicalTrials.gov 的数据,2018 年 8 月,沙特阿拉伯进行了约 121 项研究。此外,沙特阿拉伯政府还鼓励私营医疗保健部门开发和提供创新的护理模式。因此,上述因素正在推动该国市场的增长。
竞争格局和主要公司:
MEWA 健康经济学和结果研究 (HEOR) 服务市场的发展分为有机和无机增长战略。许多公司都专注于有机增长战略,例如启动、扩张、增强和搬迁。市场上出现的无机增长策略包括并购、伙伴关系和合作。这些活动为 MEWA 健康经济学和结果研究 (HEOR) 服务市场参与者的业务和客户群扩张铺平了道路。
2023 年 4 月,PharmaLex Group 宣布打算与 Cpharm 合并。借助 Cpharm 在该地区药物和器械警戒方面的专业能力,这次合并对于扩大 PharmaLex 在澳大利亚和新西兰的业务范围发挥着至关重要的作用,从而提供补充服务,从而扩大了两家公司的服务组合。 2023年3月,LEO Pharma 与 ICON plc 宣布建立战略合作伙伴关系,使 LEO Pharma 能够进行以患者为中心且具有成本效益的临床试验执行,该合作伙伴关系进一步支持公司建立有效且高效的临床组合执行的总体目标2023 年 3 月,IQVIA 与 (RED) 合作抗击艾滋病和导致流行病蔓延的不公正现象,支持加强实验室系统并拯救生命。这项价值 500 万美元的影响力合作伙伴关系将向全球基金的实验室系统集成基金提供救生资金。 2021 年 9 月,SM Health 和 Optum 宣布开展合作,主要致力于为中西部地区的人们提供更容易获得和负担得起的优质护理。 SSM Health 和 Optum 在某些职能部门(包括住院护理管理、数字化转型和收入周期管理)开展合作,以改善健康结果和患者的医疗保健体验。公司简介
PharmaLex GmbHICON PlcIQVIA Holdings IncSyneos Health IncOptum IncValue In ResearchExlService Holdings, IncClarivate氯乙烯
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Who are the major players in market the MEWA health economics & outcomes research (HEOR) services market?

The MEWA health economics & outcomes research (HEOR) services market majorly consists of the players such as PharmaLex GmbH, ICON Plc, IQVIA Holdings Inc, Syneos Health Inc, Optum Inc, Value In Research, ExlService Holdings, Inc, Clarivate Plc, and CCHO among others.

What are health economics & outcomes research (HEOR) services?

Health economics focuses on measuring and evaluating the outcomes of health interventions. Outcomes research encompasses a range of scientific disciplines that help in evaluating the impact of health interventions on patients. Therefore, health economics and outcomes research (HEOR) combines two fields to provide meaningful data and insights for healthcare decision-makers. Interest in HEOR has grown exponentially as governments and other payers grapple with how to achieve the best possible health outcomes at an affordable cost. HEOR can help healthcare decision-makers, including physicians, governments, payers, ministries of health, patients, and more, appropriately compare and select available options.

What are the driving and restraining factors for the MEWA health economics & outcomes research (HEOR) services market?

The factors that are driving the growing biotechnology & pharmaceutical companies and drug developments and increasing healthcare spending. On the other hand, restrictions on access to real-world data (RWD) is likely to hinder the growth of the market during the forecast period.

Which segment is dominating the MEWA health economics & outcomes research (HEOR) services market?

The MEWA health economics & outcomes research (HEOR) services market is analyzed in the basis of service, service provider, and end user. Based on service, the MEWA health economics & outcome research (HEOR) services market is segmented into clinical outcome, economic modelling/evaluation, market access solutions and reimbursement, and real-world data analysis and information systems. The clinical outcome segment held the largest market share in 2022. The real-world data analysis and information systems segment is predicted to register the highest CAGR during 2022–2030. The MEWA health economics & outcome research (HEOR) services market, by service provider, is bifurcated into contract research organizations and consultancy. The contract research organizations segment held a larger market share in 2022 and is anticipated to register a higher CAGR during 2022–2030. The MEWA health economics & outcome research (HEOR) services market, by end user, is segmented into biotech/pharma companies, healthcare payers, government organizations, and healthcare providers. The biotech/pharma companies segment held the largest market share in 2022 and is anticipated to register the highest CAGR during 2022–2030.

The List of Companies - MEWA Health Economics & Outcomes Research(HEOR) Market

  1. PharmaLex GmbH
  2. ICON Plc
  3. IQVIA Holdings Inc
  4. Syneos Health Inc
  5. Optum Inc
  6. Value In Research
  7. ExlService Holdings, Inc
  8. Clarivate Plc
  9. CCHO

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports